Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries

Edward Burn, Xintong Li, Kristin Kostka, Henry Morgan Stewart, Christian Reich, Sarah Seager, Talita Duarte-Salles, Sergio Fernandez-Bertolin, María Aragón, Carlen Reyes, Eugenia Martinez-Hernandez, Edelmira Marti, Antonella Delmestri, Katia Verhamme, Peter Rijnbeek, Scott Horban, Daniel R. Morales, Daniel Prieto-Alhambra*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

21 Citations (Scopus)
Original languageEnglish
Pages (from-to)495-510
Number of pages16
JournalPharmacoepidemiology and Drug Safety
Volume31
Issue number5
DOIs
Publication statusPublished - May 2022

Bibliographical note

ACKNOWLEDGEMENTS:
This study was funded by the European Medicines Agency in the form of a competitive tender (Lot ROC No EMA/2017/09/PE). The authors acknowledge Prof. Johan Van der Lei for the overall management of this research grant.

Cite this